Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Programmable Double Peptide Nucleic Acid-Locked Nucleic Acid Molecular Switch Enables Extraction-Free Direct Zygosity Discrimination of Single Nucleotide Polymorphisms.

Analytical chemistry·2026
Same author

Nipah virus destroyed my personal, family, and social life: stories of the hardship faced by Nipah survivors in Bangladesh.

International journal for equity in health·2026
Same author

Integrated Biodevice for Parallel Magnetic Isolation and Bioelectrocatalytic Detection of Circulating DNA and RNA Biomarkers in Non-Small Cell Lung Cancer Liquid Biopsy.

ACS sensors·2026
Same author

Alarming disparities of adolescent motherhood in Nigeria: results from 36 states and the Federal Capital Territory.

BMJ global health·2026
Same author

The need to strengthen Australian health and social policy to support survivors of the Stolen Generations.

BMJ global health·2026
Same author

Multiscale quantum-to-device simulation framework for Ca<sub>3</sub>AsBr<sub>3</sub> perovskite solar cells: engineering efficient electron transport layers.

Scientific reports·2026
Same journal

Utility of cerebrospinal fluid multiplex polymerase chain reaction assay in children suspected of meningitis or encephalitis in a tertiary care hospital in Thailand.

IJID regions·2026
Same journal

Molecular prevalence and socioeconomic, demographic, and behavioral risk factors of <i>Chlamydia trachomatis, Neisseria gonorrhoeae</i>, and <i>Ureaplasma</i> species among women in Mogadishu, Somalia.

IJID regions·2026
Same journal

Epidemiological trends of acute watery diarrhea (AWD) across all age groups at Cumilla General Hospital: Retrospective cross-sectional insights from AWD surveillance data of 2022 to 2024.

IJID regions·2026
Same journal

World Health Organization bacterial priority pathogens in skin and soft tissue infections: prevalence, antimicrobial resistance, and risk factors in Mwanza, Tanzania.

IJID regions·2026
Same journal

From bites to ripple effects: Unraveling the health, economic, and social effects of arboviral epidemics in Mainland France.

IJID regions·2026
Same journal

Forensic postmortem examination as sentinel evidence of rifampicin-resistant tuberculosis outside routine clinical reporting.

IJID regions·2026
See all related articles

Related Experiment Video

Updated: May 16, 2025

Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
08:37

Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control

Published on: March 30, 2015

13.5K

The Global Fund's Bangladesh program.

Md Ferdous Rahman1,2, Md Sharful Islam Khan2, M Mamun Huda1

  • 1Rural Health Research Institute, Charles Sturt University, Orange, Australia.

IJID Regions
|April 3, 2025
PubMed
Summary
This summary is machine-generated.

The Global Fund combats HIV/AIDS, TB, and malaria, saving millions globally. In Bangladesh, it faces challenges with high-risk groups and drug resistance, requiring continued support for disease elimination.

Keywords:
BangladeshGlobal fundHIVMalariaTuberculosis

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.7K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Related Experiment Videos

Last Updated: May 16, 2025

Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
08:37

Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control

Published on: March 30, 2015

13.5K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.7K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Area of Science:

  • Global health
  • Infectious disease control
  • Public health initiatives

Background:

  • The Global Fund, established in 2002, targets HIV/AIDS, tuberculosis (TB), and malaria.
  • It has mobilized significant funding, saving over 65 million lives worldwide.
  • In Bangladesh, the program has improved treatment, detection, and prevention.

Purpose of the Study:

  • To evaluate the Global Fund's impact in Bangladesh.
  • To identify persistent challenges in disease control.
  • To outline future strategies for disease elimination.

Main Methods:

  • Programmatic review of Global Fund activities in Bangladesh.
  • Analysis of disease control indicators and challenges.
  • Assessment of needs for future interventions.

Main Results:

  • Progress in expanding treatment and prevention for HIV/AIDS, TB, and malaria.
  • Persistent challenges include stigma and healthcare access for high-risk populations (people who inject drugs, sex workers, transgender individuals).
  • Growing threat of drug resistance in malaria and TB control.

Conclusions:

  • Continued Global Fund support is crucial for Bangladesh.
  • Scaling up diagnostics, community-led interventions, and cross-border collaboration are essential.
  • Effective coordination among stakeholders is vital for achieving sustainable progress and disease elimination.